The Metastasis Prize

The prize (currently 12.000€) will be awarded to scientists who convincingly show that the proposed projects will generate a new opening in metastasis research. It must be clear from the proposal how the preliminary results obtained through the prize may enable the candidate to apply competitively for a research grant from national or international organizations.

Eligibility: We fund science performed in universities or not-for-profit organizations in the countries of the European Research Community (ERC; as defined by the EU) http://cordis.europa.eu/fp7/who_en.html#countries

Following the first prize assignment in 2013 we decided to award two prizes in 2015. We selected both an early stage (Junior Prize = until 6 years after PhD)  and a more advanced stage scientist (Senior Prize = until 12 years after PhD) as awardees of the Metastasis Prize.

2017, we awarded two Senior Prizes.

In 2019 our financial situation allowed us to award 3 prizes: one Junior prize and two Senior prizes

Metastasis Prize 2021

After the call for proposals in the beginning of 2021 we obtained 20 applications divided in 7 applications for a Junior prize and 13 applications for a Senior prize.

The board members made a preselection based on the most important criteria of our foundation: an innovative idea that requires preliminary evidence before the candidate can apply for a full research grant. The board judges how the preliminary data resulting from the Metastasis Prize will facilitate follow-up research and will contribute to success in grant applications to regular national and international funding agencies. 

The most promising applications in both categories (Junior and Senior prizes) were next presented to a board of international experts to be ranked.
According to this ranking the board members decided to award again three Prizes, one Junior and two Senior Prizes.